Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ferinject® granted upgraded recommendations in 2023 ESC heart failure guidelines 2023-08-28 19:00
Antengene Announces Interim Financial Results for 2023 with New Clinical Data Highlighting the Growing Value of Its Pipeline 2023-08-25 19:37
Henlius 2023 H1 Results: Achieved record profits and RMB2.5 billion revenues, opening a new chapter of high-quality growth 2023-08-25 19:26
3SBio announces 2023 interim results, with revenue growing over 20% year on year and pipeline value constantly enhanced 2023-08-25 10:06
Everest Medicines Announces New Drug Application Acceptance by the Pharmaceutical Administration Bureau of Macao for Nefecon® for the Treatment of Primary IgA Nephropathy 2023-08-25 08:15
Antheia Achieves Major Commercial Milestone 2023-08-25 08:01
YS Biopharma Announces Purchase of Shares by Company Officers 2023-08-25 04:15
Everest Medicines Announces Interim Results for First Half of 2023 2023-08-24 08:15
Salvia BioElectronics: First-Ever Patient Treated with Breakthrough Neuromodulation Solution for Severe Migraine and Cluster Headache in Australia 2023-08-24 05:45
MGI Partners with NGeneBio to Advance Precision Medicine 2023-08-23 09:00
Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results 2023-08-22 22:00
Paradigm Therapeutics Acquires Late Stage "Breakthrough Therapy" Designated Therapy for Treatment of All Subtypes of Epidermolysis Bullosa (EB) 2023-08-22 21:13
Hummingbird Bioscience to Present Poster on HMBD-001 Combination Strategy for Squamous Non-Small Cell Lung Cancer at World Conference on Lung Cancer 2023 2023-08-21 17:58
3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling 2023-08-18 22:45
QiLu Pharmaceutical's Iruplinalkib Phase III INSPIRE Study Researched Primary Endpoint and was Selected for 2023 WCLC Oral Presentation 2023-08-18 09:50
Novo Holdings participates in $290m strategic financing of Sangon Biotech 2023-08-17 09:44
Innovent Announces the NMPA Approval of SINTBILO® (Tafolecimab Injection) for the Treatment of Adult Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia 2023-08-17 08:00
Oncoclínicas Group generated record earnings in the second quarter of 2023, R$309 million and a net profit of R$35 million 2023-08-16 19:00
MGI Unveils Latest MGISP-NEX and MGIFLP-L50 Automation Systems at Medlab Asia & Asia Health 2023 2023-08-16 11:00
Transcenta to Present Three Study Results at ESMO 2023 2023-08-16 08:00
1 24 25 26 27 28 212